Biologics News
-
Biologics | News | 0 Comment | 12 Apr, 2024
Serum Institute of India (SII), the world’s largest vaccine manufacturer, has joined forces with Univercells,...Read more
-
Biocon Biologics partners with Sandoz Australia for cancer biosimilars
Biologics | News | 0 Comment | 09 Feb, 2024
Indian firm Biocon Biologics Ltd (BBL), a fully integrated biosimilars company and subsidiary of Biocon, has announ...Read more
-
MarkHerz and Polyplus Collaborate to Advance Cell and Gene Therapy Process Standards and Lower Costs
Biologics | News | 0 Comment | 19 Dec, 2023
The teams will work to improve process efficiency leveraging Polyplus products and expertise with MarkHerz man...Read more
-
Problem-solving in upstream bioprocessing
Biologics | News | 0 Comment | 22 Aug, 2023
The field of cell and gene therapies is a new and emerging category of seeking methods to cure diseases by restoring or ...Read more
-
Israel's MediWound announces launch of biologic drug NexoBrid in Japan
Biologics | News | 0 Comment | 02 Aug, 2023
Israel-based biopharma firm MediWound has announced that its strategic partner, Kaken Pharmaceutical has launched NexoBr...Read more
-
US-based Rani Therapeutics expands biologics partnership with Korean firm Celltrion
Biologics | News | 0 Comment | 08 Jun, 2023
Rani Therapeutics Holdings, a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs...Read more
-
Biologics | News | 0 Comment | 23 May, 2023
Current prenatal diagnostic methods are highly invasive, carrying risk of miscarriage, infection, and injury to the foet...Read more
-
LogiPharma to launch life sciences supply chain conference summit in Singapore (June 2023)
Biologics | Company results | 0 Comment | 28 Mar, 2023
LogiPharma, the global life sciences supply chain conference brand will be holding its inaugural Asian summit from June ...Read more
-
Register Now :10x Genomics to host APAC Spatial Biology Symposium on November 22
Biologics | News | 0 Comment | 01 Nov, 2022
The future of spatial is here. Join us: https://10xgen.com/3fn3FZw Advances in spatial technologi...Read more
-
Biocon out-licenses two biosimilar assets for commercialization in Japan
Biologics | News | 0 Comment | 17 Oct, 2022
Indian firm Biocon Biologics has entered into a strategic out-licensing agreement with Japanese pharmaceuticals com...Read more
-
Pall Corporation Launches Three New Allegro™ Connect Systems
Biologics | News | 0 Comment | 27 Sep, 2022
Pall Corporation extends its bioprocessing solution portfolio with the launch of three new Allegro Connect Systems. In c...Read more
-
Thermo Fisher invests $160 M to expand bioproduction capacity in Greater Boston
Biologics | News | 0 Comment | 20 Sep, 2022
Thermo Fisher Scientific Inc., the world leader in serving science, has opened a new biomanufacturing facility in Chelms...Read more
-
Biologics | News | 0 Comment | 08 Sep, 2022
The new in vivo-jetRNA®+ transfection reagent an efficient, stable, and safe delivery system leading to 100% mR...Read more
-
Japan's EditForce & Mitsubishi ink gene therapy deal for ¥20 B
Biologics | News | 0 Comment | 05 Jul, 2022
Japan-based EditForce has entered into a license agreement with Mitsubishi Tanabe Pharma Corporation (MTPC) to research,...Read more
-
VerImmune and Fosun Pharma focus on virus-inspired particle based novel immunotherapies in China
Biologics | News | 0 Comment | 23 May, 2022
US-based startup VerImmune and Fosun Pharma in China have entered into an exclusive license and option agreement. ...Read more
-
South Korean firms lay focus on immune cell therapy
Biologics | News | 0 Comment | 29 Apr, 2022
Daewoong Pharmaceutical has signed a joint research and development agreement with UCI Therapeutics (CEO Sooyoung Jung),...Read more
-
Korean startup ImmuneOncia enhances biologics portfolio for cancer patients
Biologics | News | 0 Comment | 28 Dec, 2021
ImmuneOncia Therapeutics, Inc., a clinical-stage, immuno-oncology startup in South Korea, has announced that a Memorandu...Read more
-
'Biocon Biologics to work with RSSDI to train ~400 HCPs in India'
Biologics | Opinion | 2 Comment | 01 Dec, 2021
What additional scientific data did you have to submit to the US FDA for obtaining interchangeable biosimilar approval f...Read more
